OpenVSafe by OpenVAERS
Search V-safe

ARB-17014-50556

3 vaccinations 10 coded responses 30 check-ins 10 free-text entries 2 call cases
Sex
Male
Age at first dose
66+
ZIP prefix
010 / MA
Registered
2021-04-08
Relationship
Self
Race
N/A
Ethnicity
N/A

Timeline

  1. 2021-03-23
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-08
    Registered in v-safe
  3. 2021-04-08
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  4. 2021-04-13
    Dose 2 — Pfizer-BioNTech
  5. 2021-04-13
    Health check-in — day 0, dose 2
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  6. 2021-04-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  7. 2021-04-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  8. 2021-04-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  9. 2021-04-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache · Be unable to do your normal daily activities
    Adult check-in
  10. 2021-04-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-04-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  12. 2021-04-20
    Health check-in — day 7, dose 2
    Feeling: Good · None · Be unable to do your normal daily activities
    Adult check-in
  13. 2021-04-27
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-05-04
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-05-11
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-05-18
    Survey response — day 35, dose 2
    MedDRA: Fatigue, Headache — Feeling: Good · Be unable to work, Be unable to do your normal daily activities
    Free text: Chronic fatigue. Headaches.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-05-25
    Survey response — day 42, dose 2
    MedDRA: Decreased appetite, Headache, Musculoskeletal stiffness, Nausea, Oral pain — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities
    Free text: Dull headache. Mouth pain. Nausea. Stiff neck. Loss of appetite. No fever.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-07-13
    Survey response — 3 months, dose 2
    MedDRA: Apathy, Depression, Fatigue, Headache — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Headaches. Fatigue. Lack of ambition. Mild depression.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-10-12
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-10-13
    Dose 3 — Pfizer-BioNTech
  21. 2021-10-13
    Survey response — day 0, dose 3
    MedDRA: Cough, Productive cough, Self-medication, Sinus congestion, Sinus headache — Feeling: Fair · Chills, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Severe sinus congestion NOT remedied by 400 mg Guaifenesin. So I have phlegm and a cough. Slight sinus headache.
    MedDRA releases: 2024-11 · check-in free text available
  22. 2021-10-14
    Survey response — days 1–6 daily, dose 3
    MedDRA: Cough — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Occasional cough.
    MedDRA releases: 2024-11 · check-in free text available
  23. 2021-10-16
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  24. 2021-10-17
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  25. 2021-10-18
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  26. 2021-10-19
    Survey response — days 1–6 daily, dose 3
    MedDRA: Cough, Hypersensitivity, Nasal congestion, Respiratory tract congestion, Self-medication — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Severe nasal and chest congestion last night with coughing after eating simple foods I eat all the time. I had to take 400 mg guaifenesin to relieve the allergic reaction to something unknown.
    MedDRA releases: 2024-11 · check-in free text available
  27. 2021-10-20
    Health check-in — day 7, dose 3
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  28. 2021-10-27
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  29. 2021-11-03
    Survey response — day 21, dose 3
    MedDRA: Vomiting — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Possible bad food last night after a campaign party. No alcohol for me. But I threw up after I got home and took generic Compazine. I can still taste greasy sausage or pepperoni which I usually avoid.
    MedDRA releases: 2024-11 · check-in free text available
  30. 2021-11-17
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  31. 2021-11-24
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  32. 2022-01-12
    Survey response — 3 months, dose 3
    MedDRA: Fatigue, Pre-existing disease, Respiratory tract congestion, Sinus congestion — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Frequent sinus and chest congestion which is cleared by Guaifenesin, one 400 mg dose per day. Might be pollen and dust allergies. Frequent fatigue requiring naps. Might be due to Follicular Lymphoma previously diagnosed as stable.
    MedDRA releases: 2024-11 · check-in free text available
  33. 2022-04-15
    Survey response — 6 months, dose 3
    MedDRA: Hospitalisation, Pneumonia, Pulmonary thrombosis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization
    Free text: Severe pneumonia with many small blood clots throughout both lungs. This required hospitalization and my now taking Eliquis, a powerful blood thinner, twice per day. I previously had ALL pneumonia vaccines recommended for those over 65.
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-04-15
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  35. 2022-04-19
  36. 2022-04-19
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  37. 2022-10-13
    Survey response — 12 months, dose 3
    MedDRA: Fatigue, Office visit, Pulmonary infarction, Pulmonary mass — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Extreme fatigue. Pulmonologist continues to develop a diagnosis, but believes I suffered a pulmonary infarct and now have a large mass in one lung. I have been told I should take 5 mg Eliquis, an anticoagulant, every 12 h for the rest of my life.
    MedDRA releases: 2024-11 · check-in free text available
  38. 2022-10-13
    Report sent to call center — 12 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  39. 2022-10-14
  40. 2022-10-14
    Call successful
    Does not wish to fill out VAERS report

Vaccinations

DoseDateManufacturerCo-administered
12021-03-23Pfizer-BioNTech
22021-04-13Pfizer-BioNTech
32021-10-13Pfizer-BioNTech No

Call center

2 call center cases

2 successful

See the call center timeline

Free text

Release 8 — day 35, dose 2

2021-05-18

Symptoms: Chronic fatigue. Headaches.

Release 8 — day 42, dose 2

2021-05-25

Symptoms: Dull headache. Mouth pain. Nausea. Stiff neck. Loss of appetite. No fever.

Release 9 — 3 months, dose 2

2021-07-13

Symptoms: Headaches. Fatigue. Lack of ambition. Mild depression.

Release 10 — day 0, dose 3

2021-10-13

Systemic reaction (other): Severe sinus congestion NOT remedied by 400 mg Guaifenesin. So I have phlegm and a cough. Slight sinus headache.

Release 10 — days 1–6 daily, dose 3

2021-10-14

Systemic reaction (other): Occasional cough.

2021-10-19

Systemic reaction (other): Severe nasal and chest congestion last night with coughing after eating simple foods I eat all the time. I had to take 400 mg guaifenesin to relieve the allergic reaction to something unknown.

Release 10 — day 21, dose 3

2021-11-03

Symptoms: Possible bad food last night after a campaign party. No alcohol for me. But I threw up after I got home and took generic Compazine. I can still taste greasy sausage or pepperoni which I usually avoid.

Release 10 — 3 months, dose 3

2022-01-12

Symptoms: Frequent sinus and chest congestion which is cleared by Guaifenesin, one 400 mg dose per day. Might be pollen and dust allergies. Frequent fatigue requiring naps. Might be due to Follicular Lymphoma previously diagnosed as stable.

Release 11 — 6 months, dose 3

2022-04-15

Symptoms: Severe pneumonia with many small blood clots throughout both lungs. This required hospitalization and my now taking Eliquis, a powerful blood thinner, twice per day. I previously had ALL pneumonia vaccines recommended for those over 65.

Release 12 — 12 months, dose 3

2022-10-13

Symptoms: Extreme fatigue. Pulmonologist continues to develop a diagnosis, but believes I suffered a pulmonary infarct and now have a large mass in one lung. I have been told I should take 5 mg Eliquis, an anticoagulant, every 12 h for the rest of my life.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDApathy ✓ ✓ ✓
SDDecreased appetite ✓ ✓ ✓
SDDepression ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDHospitalisation · · ✓
SDMusculoskeletal stiffness ✓ ✓ ✓
SDNausea ✓ ✓ ✓
SDOffice visit · · ✓
SDOral pain ✓ ✓ ✓
SDPneumonia · · ✓
SDPre-existing disease · · ✓
SDPulmonary infarction · · ✓
SDPulmonary mass · · ✓
SDPulmonary thrombosis · · ✓
SDRespiratory tract congestion · · ✓
SDSinus congestion · · ✓
SDVomiting · · ✓
SROCough · · ✓
SROHypersensitivity · · ✓
SRONasal congestion · · ✓
SROProductive cough · · ✓
SRORespiratory tract congestion · · ✓
SROSelf-medication · · ✓
SROSinus congestion · · ✓
SROSinus headache · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release